Stay updated on Fracture Risk Assessment in Osteoporotic Women Clinical Trial
Sign up to get notified when there's something new on the Fracture Risk Assessment in Osteoporotic Women Clinical Trial page.

Latest updates to the Fracture Risk Assessment in Osteoporotic Women Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 added; the government funding notice and Revision: v3.4.1 were removed. These are minor site maintenance updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedDisplayed a system notice about a lapse in government funding and open status of the NIH Clinical Center, with links to cc.nih.gov and opm.gov. Updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check28 days agoChange DetectedGlossary display was added; metadata labels were updated (including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and the revision label updated to 'Revision: v3.4.0' (replacing 'v3.3.4').SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous v3.3.3 revision. This is a minor platform update with no changes to the study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Revision: v3.3.3; removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Fracture Risk Assessment in Osteoporotic Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fracture Risk Assessment in Osteoporotic Women Clinical Trial page.